GMP Cell Therapy Consumables Market Trends That Will Shape the Next Decade: Insights from Advancements in GMP-Compliant CD34+ Hematopoietic Stem Cells: OrganaBio's Launch and Industry Developments

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the GMP Cell Therapy Consumables Market Size By 2025?
In recent times, the market size of GMP cell therapy consumables has seen rapid expansion. The market is expected to rise from $17.85 billion in 2024 and reach a sizing of $22.87 billion in 2025, representing a compound annual growth rate (CAGR) of 28.1%. Factors such as increased investment in regenerative medicine, improved cell therapy research, clinical trials and approvals, the mounting incidence of chronic illnesses, and the heightened understanding of personalized medicine have all contributed to the growth observed in the historical period.

How Big Is the GMP Cell Therapy Consumables Market Size Expected to Grow by 2029?
The market size of GMP cell therapy consumables is anticipated to witness a tremendous increase in the coming years. It is predicted to reach $59 billion in 2029 with a CAGR of 26.7%. The surge during the forecasted period is linked to the expansion of cell therapy applications, a worldwide increase in cell therapy trials, regulatory backing for cell therapies, the introduction of sophisticated cell therapy platforms, and the globalization of cell therapy manufacturing. Key trends projected in the forecast period encompass investment in manufacturing infrastructure, technological innovation in cell processing, collaborative initiatives and partnerships, digitization and data integration, along with strategic alliances and mergers.

View the full report here:
https://www.thebusinessresearchcompany.com/report/gmp-cell-therapy-consumables-global-market-report

Which Key Market Drivers Powering GMP Cell Therapy Consumables Market Expansion and Growth?
The upward trend in drug discovery is projected to be a key driver for the expansion of the GMP cell therapy consumables market. Drug discovery encompasses finding new potential medicinal substances by merging computational, clinical, experimental, and translational models. Breakthroughs in bioinformatics, genetics, molecular biology, and high-throughput screening techniques have transformed the realm of drug discovery. These cutting-edge technologies empower researchers to better comprehend disease mechanisms, pinpoint drug targets, and screen vast compound libraries for potent drug contenders more proficiently. This surge in drug discovery is boosting the GMP cell therapy consumables market. For example, in January 2023, the Food and Drug Administration - a federal agency under the US Department of Health and Human Services, reported that the FDA's Centre for Drug Evaluation and Research (CDER) approved 37 new drugs and therapeutic biological products in the US in 2022 for various medical conditions. As a result, the surge in drug discovery is fueling the expansion of the GMP cell therapy consumables market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12014&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the GMP Cell Therapy Consumables Market?
Leading firms in the GMP cell therapy consumables market are producing GMP-compliant CD34+ hematopoietic stem cells (HSCs) to assist advanced therapies. GMP-compliant CD34+ HSCs are a unique type of stem cell that exhibit the CD34 marker on their surface and are produced corresponding to Good Manufacturing Practice (GMP) standards. For example, in April 2024, the US-based pharmaceutical firm OrganaBio presented HematoPAC-HSC-CB-GMP, a readily accessible source of GMP-compliant CD34+ HSCs obtained from fresh human umbilical cord blood. OrganaBio calls upon its vast experience in cell isolation and GMP production to generate abundant amounts of highly viable CD34+ HSCs within a day of collection. The introduction of this product is geared towards fostering the advancement of next-generation treatments, including therapies for blood cancers and genetic disorders.

What Are the Emerging Segments in the GMP Cell Therapy Consumables Market?
The GMP cell therapy consumables market covered in this report is segmented -

1) By Product: Kits, Reagents Or Molecular Biology reagents, Growth Factors Or Cytokines And Interleukins, Other Products
2) By Cell Therapy: NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, Other cell therapies
3) By Process: Cell Collection And Characterization Or Sorting And Separation, Cell Culture And Expansion Or Preparation, Cryopreservation, Cell Processing And Formulation, Cell Isolation And Activation, Cell Distribution Or Handling, Process Monitoring And Control Or Readministration Or Quality Assurance, Other Processes
4) By End-Use: Clinical, Commercial, Research

Subsegments:
1) By Kits: Cell Culture Kits, Cell Isolation Kits, Transfection Kits
2) By Reagents Or Molecular Biology Reagents: Buffers And Solutions, Enzymes, Staining Reagents
3) By Growth Factors Or Cytokines And Interleukins: Hematopoietic Growth Factors, Antibody Cytokines, Immunomodulatory Cytokines
3) By Other Products: Cell Culture Vessels, Bioreactors, Media And Supplements

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12014&type=smp

Who Are the Global Leaders in the GMP Cell Therapy Consumables Market?
Major companies operating in the GMP cell therapy consumables market include Thermo Fisher Scientific Inc., Fresenius Kabi AG, Danaher Corporation, Merck KGaA, Asahi Kasei Corporation, GE HealthCare Technologies Inc., Corning Incorporated, Avantor Inc., Lonza Group AG, Terumo Corporation, Catalent Inc., Sartorius AG, Bio-Techne Corp, Repligen Corporation, Miltenyi Biotec BV & Co KG, Genscript Biotech Corporation, Rentschler Biopharma SE, FUJIFILM Irvine Scientific Inc., BioLegend Inc., STEMCELL Technologies Inc., BioLife Solutions Inc., Abzena Ltd., Sino Biological Inc., ProBioGen AG, MaxCyte Inc., PromoCell GmbH, PeproTech Inc., Cellares Corp., Wilson Wolf Corporation, Cellexus Ltd.

Which are the Top Profitable Regional Markets for the GMP Cell Therapy Consumables Industry?
North America was the largest region in the GMP cell therapy consumables market in 2024. Asia-pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the GMP cell therapy consumables market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12014

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.